Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.50
Delayed Data
As of Dec 08
 +0.20 / +1.40%
Today’s Change
7.86
Today|||52-Week Range
16.95
-2.29%
Year-to-Date
Teva Copaxone EU Label to Omit Pregnancy Contraindication
Dec 07 / Zacks.com - Paid Partner Content
Company News for November 30, 2016
Nov 30 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
Dec 06 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for...
Nov 30 / Zacks.com - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?
Nov 29 / MotleyFool.com - Paid Partner Content